On April 23, the following stocks were determined to be overbought: Catalyst Health Solutions, Inc, Ardea Biosciences, Inc, ZOLL Medical Corp, Human Genome Sciences Inc, and Transcend Services, Inc. The demand for these stocks have pushed the prices of the underlying assets to levels that do not support the fundamentals. This is interpreted as a sign that the stocks are overvalued and may experience a pullback.
Shares of Catalyst Health Solutions, Inc (CHSI) fell by 1.50% or $-1.34/share to $88.27. In the past year, the shares have traded as low as $45.35 and as high as $92.62. On average, 597920 shares of CHSI exchange hands on a given day and today's volume is recorded at 315298.
Shares of Ardea Biosciences, Inc (RDEA) traded higher by 51.54% or $10.74/share to $31.58. In the past year, the shares have traded as low as $13.15 and as high as $29.06. On average, 276470 shares of RDEA exchange hands on a given day and today's volume is recorded at 18617692.
Shares of ZOLL Medical Corp (ZOLL) traded higher by 0.05% or $0.05/share to $92.95. In the past year, the shares have traded as low as $33.84 and as high as $93.65. On average, 570100 shares of ZOLL exchange hands on a given day and today's volume is recorded at 35511.
Shares of Human Genome Sciences Inc (HGSI) traded higher by 0.28% or $0.04/share to $14.4. In the past year, the shares have traded as low as $6.51 and as high as $30.00. On average, 9102870 shares of HGSI exchange hands on a given day and today's volume is recorded at 2420659.
Shares of Transcend Services, Inc (TRCR) remained unchanged at $29.5. In the past year, the shares have traded as low as $19.00 and as high as $30.25. On average, 413970 shares of TRCR exchange hands on a given day and today's volume is recorded at 21047.
